FAGIUOLI STEFANO

Position:
Role
Full Professor  
Academic disciplines
Gastroenterologia (MED/12)
Office phone

Publications

  • Piñero, F., Costentin, C., Degroote, H., Notarpaolo, A., Boin, I., Boudjema, K., et al. (2023). AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool. JHEP REPORTS, 5(2) [10.1016/j.jhepr.2022.100644]. Detail

  • Vigano, M., Beretta, M., Lepore, M., Abete, R., Benatti, S., Grassini, M., et al. (2023). Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients. VACCINES, 11(10) [10.3390/vaccines11101611]. Detail

  • Magro, B., Triolo, M., Celsa, C., Pagano, D., Cabibbo, G., Cammà, C., et al. (2023). Systemic treatment for hepatocellular carcinoma beyond milan criteria on the waitlist: is it time for a neoadjuvant therapy?. HEPATOMA RESEARCH, 9 [10.20517/2394-5079.2023.38]. Detail

  • Riggio, O., Celsa, C., Calvaruso, V., Merli, M., Caraceni, P., Montagnese, S., et al. (2023). Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study. FRONTIERS IN MEDICINE, 10 [10.3389/fmed.2023.1184860]. Detail

  • Fagiuoli, S., Toniutto, P., Coppola, N., Ancona, D., Andretta, M., Bartolini, F., et al. (2023). Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA). THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 19, 57-65 [10.2147/TCRM.S394467]. Detail